Long-lasting Complete Remission Following Immunotherapy With Anti-PD1 Plus Anti-CTLA4 in a Polymetastatic Patient With NRAS (Q16R) Mutated Anaplastic Thyroid Carcinoma

The combination of pembrolizumab plus ipilimumab may represent a therapeutic strategy in patients with NRAS (Q16R) mutated anaplastic thyroid cancer.

Authors

Institutions

Publication Details

Journal
Anticancer Research
Published
2025-08-28
DOI
https://doi.org/10.21873/anticanres.17740
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-lasting Complete Remission Following Immunotherapy With Anti-PD1 Plus Anti-CTLA4 in a Polymetastatic Patient With NRAS (Q16R) Mutated Anaplastic Thyroid Carcinoma

Sergio Del Bianco, Dimitri Anzellini, M. Loddo
Anticancer Research
Cancer Immunotherapy and Biomarkers
article

Long-lasting Complete Remission Following Immunotherapy With Anti-PD1 Plus Anti-CTLA4 in a Polymetastatic Patient With NRAS (Q16R) Mutated Anaplastic Thyroid Carcinoma

Sergio Del Bianco, Dimitri Anzellini, M. Loddo
article en

Abstract

The combination of pembrolizumab plus ipilimumab may represent a therapeutic strategy in patients with NRAS (Q16R) mutated anaplastic thyroid cancer.

Anticancer ResearchVol. 45(9)
BioClinica (United States) (US)
Good health and well-being
Openalex Percentile: Top 69%
Cancer Immunotherapy and Biomarkers
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Long-lasting Complete Remission Following Immunotherapy With Anti-PD1 Plus Anti-CTLA4 in a Polymetastatic Patient With NRAS (Q16R) Mutated Anaplastic Thyroid Carcinoma — Sergio Del Bianco, Dimitri Anzellini, et al. · Anticancer Research (2025) | TGRS Research Map | TGRS